{"id":565253,"date":"2025-02-05T18:32:25","date_gmt":"2025-02-06T02:32:25","guid":{"rendered":"https:\/\/nai500.com\/?p=565253"},"modified":"2025-02-05T18:32:25","modified_gmt":"2025-02-06T02:32:25","slug":"%e7%be%8e%e8%82%a1%e5%9f%ba%e5%9b%a0%e7%bb%84%e8%82%a1%e7%a5%a8%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97-%e6%9c%a8%e5%a4%b4%e5%a7%90-%e5%9f%ba%e5%9b%a0%e7%bb%84%e9%9d%a9%e5%91%bd","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/02\/%e7%be%8e%e8%82%a1%e5%9f%ba%e5%9b%a0%e7%bb%84%e8%82%a1%e7%a5%a8%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97-%e6%9c%a8%e5%a4%b4%e5%a7%90-%e5%9f%ba%e5%9b%a0%e7%bb%84%e9%9d%a9%e5%91%bd\/","title":{"rendered":"\u7f8e\u80a1\u57fa\u56e0\u7ec4\u80a1\u7968\u6295\u8d44\u6307\u5357\uff1a\u62bc\u6ce8\u6728\u5934\u59d0\u7684\u201c\u57fa\u56e0\u7ec4\u9769\u547d\u201d"},"content":{"rendered":"<p>\u8fc7\u53bb\u51e0\u5e74\uff0c\u57fa\u56e0\u7ec4\u9886\u57df\u7684\u53d1\u5c55\u8ba9\u6295\u8d44\u8005\u770b\u5230\u4e86\u771f\u6b63\u7684\u672a\u6765\u6f5c\u529b\u3002\u57fa\u56e0\u7ec4\u5b66\u6240\u7814\u7a76\u7684\u662f\u57fa\u56e0\u5982\u4f55\u5f71\u54cd\u4eba\u7c7b\u5065\u5eb7\u53ca\u75be\u75c5\uff0c\u968f\u7740\u6d4b\u5e8f\u6280\u672f\u6210\u672c\u7684\u964d\u4f4e\u4e0e\u7cbe\u5ea6\u7684\u63d0\u5347\uff0c\u4e00\u5927\u6279\u4e13\u6ce8\u4e8e\u57fa\u56e0\u7ec4\u7814\u7a76\u7684\u4f01\u4e1a\u76f8\u7ee7\u6d8c\u73b0\uff0c\u8fd9\u4e5f\u4e3a\u6295\u8d44\u8005\u62bc\u6ce8\u7f8e\u80a1\u57fa\u56e0\u7ec4\u80a1\u7968\u63d0\u4f9b\u4e86\u591a\u6837\u5316\u7684\u9009\u62e9\u3002<\/p>\n<p>\u65b9\u821f\u6295\u8d44\uff08Ark Investment Management\uff09\u7684\u201c\u6728\u5934\u59d0\u201d\u5c31\u66fe\u63d0\u51fa\u201c\u57fa\u56e0\u7ec4\u9769\u547d\u201d\u8fd9\u4e00\u5b8f\u5927\u7406\u5ff5\uff0c\u8ba4\u4e3a\u8be5\u9886\u57df\u7684\u7a81\u7834\u5c06\u5f15\u9886\u65b0\u4e00\u4ee3\u7684\u533b\u7597\u9769\u547d\u3002\u7136\u800c\uff0c\u5c3d\u7ba1\u6280\u672f\u8fdb\u6b65\u663e\u8457\uff0c\u8fd9\u4e9b\u516c\u53f8\u80a1\u4ef7\u8868\u73b0\u5e76\u4e0d\u603b\u662f\u5f88\u7406\u60f3\uff0c2020\u5e74\u81f32024\u5e74\u95f4\uff0c\u6807\u666e\u751f\u7269\u79d1\u6280\u7cbe\u9009\u884c\u4e1a\u6307\u6570S&amp;P Biotechnology Select Industry Index\u4e0d\u6da8\u53cd\u8dcc\u3002<\/p>\n<p>\u5c55\u671b\u672a\u6765\uff0c\u6295\u8d44\u8005\u53ef\u4ee5\u5173\u6ce8\u4ee5\u4e0b\u57fa\u56e0\u7ec4\u884c\u4e1a\u7684\u4e09\u4e2a\u5927\u7c7b\uff1a<\/p>\n<ul>\n<li>\u7b2c\u4e00\u662f\u57fa\u56e0\u6d4b\u5e8f\u4e0e\u5206\u6790\uff1b<\/li>\n<li>\u7b2c\u4e8c\u662f\u57fa\u56e0\u68c0\u6d4b\u4e0e\u8bca\u65ad\uff1b<\/li>\n<li>\u7b2c\u4e09\u662f\u57fa\u56e0\u7f16\u8f91<\/li>\n<\/ul>\n<h2>2025\u5e74\u7cbe\u9009\u7f8e\u80a1\u57fa\u56e0\u7ec4\u80a1\u7968<\/h2>\n<p>\u5728\u6d4b\u5e8f\u9886\u57df\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ILMN\">Illumina\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aILMN\uff09<\/a>\u62e5\u6709\u7edd\u5bf9\u5e02\u573a\u4e3b\u5bfc\u5730\u4f4d\uff0c\u6d4b\u5e8f\u4eea\u5168\u7403\u88c5\u673a\u91cf\u8d852.5\u4e07\u53f0\uff0c\u5168\u7403\u5e02\u573a\u4efd\u989d\u572880%\u5de6\u53f3\u3002\u8be5\u516c\u53f8\u7684\u77ed\u8bfb\u957f\u6d4b\u5e8f\u6280\u672f\u4e3a\u8bb8\u591a\u7814\u7a76\u4e0e\u4e34\u5e8a\u5e94\u7528\u63d0\u4f9b\u4e86\u57fa\u7840\u3002\u968f\u7740\u764c\u75c7\u68c0\u6d4b\u4e0e\u5168\u57fa\u56e0\u7ec4\u5206\u6790\u7684\u6301\u7eed\u589e\u957f\uff0c\u8be5\u516c\u53f8\u7684NovaSeq X\u6d4b\u5e8f\u5e73\u53f0\u9010\u6e10\u6210\u4e3a\u516c\u53f8\u4e1a\u7ee9\u7684\u91cd\u8981\u63a8\u52a8\u529b\u3002\u5c3d\u7ba1Illumina\u57282024\u5e74\u524d\u4e09\u5b63\u5ea6\u7684\u8425\u6536\u540c\u6bd4\u4e0b\u964d5.1%\uff0c\u4f46\u5b83\u5728\u6d4b\u5e8f\u5e02\u573a\u7684\u9f99\u5934\u5730\u4f4d\u4ecd\u7136\u7a33\u56fa\u3002<\/p>\n<p>\u4e13\u6ce8\u4e8eRNA\u7597\u6cd5\u7684Avidity Biosciences\uff08RNA\uff09\u81f4\u529b\u4e8e\u6297\u4f53\u5be1\u6838\u82f7\u9178\u5076\u8054\u7269\uff08AOCs\uff09\u3002AOC\u878d\u5408\u4e86\u5be1\u6838\u82f7\u9178\u6280\u672f\u548c\u6297\u4f53\u7684\u4f18\u52bf\uff0c\u88ab\u8ba4\u4e3a\u5177\u6709\u63d0\u4f9b\u7cbe\u786e\u9776\u5411\u6cbb\u7597\u7684\u6f5c\u529b\u3002\u516c\u53f8\u4e34\u5e8a\u7814\u53d1\u7ba1\u7ebf\u805a\u7126\u5305\u62ec\u808c\u8425\u517b\u4e0d\u826f\u5728\u5185\u7684\u4e09\u79cd\u7f55\u89c1\u808c\u8089\u75be\u75c5\uff0c\u5019\u9009\u836f\u7269\u5206\u522b\u4e3aDel-desiran (AOC 1001)\u3001del-brax (AOC 1020)\uff0c\u4ee5\u53cadel-zota (AOC 1044)\u3002\u76ee\u524d\u516c\u53f8\u867d\u672a\u76c8\u5229\uff0c\u4f46\u57282024\u5e74\u516c\u5e03\u4e86\u79ef\u6781\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\uff0c\u4e5f\u56e0\u6b64\u5438\u5f15\u4e86\u76f8\u5f53\u591a\u7684\u5e02\u573a\u5173\u6ce8\u3002<\/p>\n<p>Exact Sciences\uff08EXAS\uff09\u51ed\u501f\u5bb6\u7528\u7ed3\u80a0\u764c\u7b5b\u67e5\u4ea7\u54c1\u201cCologuard\u201d\u5d2d\u9732\u5934\u89d2\uff0c\u540c\u65f6\u901a\u8fc7\u6536\u8d2dGenomic Health\u5c06\u764c\u75c7\u8bca\u65ad\u5e73\u53f0Oncotype DX\u7eb3\u5165\u81ea\u5df1\u7684\u4ea7\u54c1\u7ebf\u3002\u672a\u6765\uff0c\u8be5\u516c\u53f8\u8fd8\u5c06\u4e0a\u5e02\u5206\u5b50\u6b8b\u7559\u75c5\u68c0\u6d4b\u4ea7\u54c1Oncodetect\u548c\u6cdb\u764c\u65e9\u7b5b\u4ea7\u54c1Cancerguard\u3002Exact Sciences\u9884\u8ba1\u5168\u5e74\u6536\u5165\u5c06\u540c\u6bd4\u589e\u957f10%\u81f328\u4ebf\u7f8e\u5143\uff0c\u540c\u65f6\u9884\u8ba12026\u5e74\u5b9e\u73b0\u51c0\u5229\u6da6\u8f6c\u6b63\u3002<\/p>\n<p>\u57fa\u56e0\u68c0\u6d4b\u516c\u53f8Fulgent Testing\uff08FLGT\uff09\u56e0\u63d0\u4f9b\u8d85\u8fc718,000\u79cd\u68c0\u6d4b\u9879\u76ee\u800c\u53d7\u5230\u533b\u751f\u4e0e\u60a3\u8005\u7684\u5e7f\u6cdb\u9752\u7750\u3002\u8fd9\u4e9b\u9879\u76ee\u4e0d\u4ec5\u6db5\u76d6\u764c\u75c7\u7b5b\u67e5\uff0c\u4e5f\u6d89\u53ca\u7f55\u89c1\u75be\u75c5\u53ca\u65b0\u751f\u513f\u57fa\u56e0\u68c0\u6d4b\u30022024\u5e74\u7b2c\u4e09\u5b63\u5ea6\uff0c\u516c\u53f8\u6838\u5fc3\u6536\u5165\uff08\u4e0d\u542b\u65b0\u51a0\u68c0\u6d4b\uff09\u540c\u6bd4\u589e\u957f9%\uff0c\u663e\u793a\u51fa\u591a\u5143\u5316\u4ea7\u54c1\u7ebf\u7684\u97e7\u6027\u3002<\/p>\n<p>Ionis Pharmaceuticals\uff08IONS\uff09\u5219\u5728RNA\u9776\u5411\u836f\u7269\u7814\u53d1\u4e2d\u79ef\u7d2f\u4e86\u6df1\u539a\u7684\u5b9e\u529b\uff0c\u8054\u624bBiogen\u63a8\u51fa\u4e86\u9996\u6b3e\u9488\u5bf9ALS\uff08\u808c\u840e\u7f29\u6027\u810a\u9ad3\u4fa7\u7d22\u786c\u5316\u75c7\uff09\u57fa\u56e0\u81f4\u75c5\u539f\u56e0\u7684\u836f\u7269Qalsody\u3002\u516c\u53f8\u660e\u661f\u4ea7\u54c1Spinraza\u662f\u6700\u5927\u7684\u6536\u5165\u6765\u6e90\uff0c\u4e3a\u516c\u53f8\u5b75\u5316\u66f4\u591a\u521b\u65b0\u836f\u7269\u63d0\u4f9b\u8d44\u91d1\u652f\u6301\u3002\u867d\u7136Ionis\u5c1a\u672a\u76c8\u5229\uff0c\u4f46\u5145\u8db3\u7684\u73b0\u91d1\u50a8\u5907\uff0825\u4ebf\u7f8e\u5143\uff09\u4ee5\u53ca\u591a\u9879\u6b63\u5728\u63a8\u8fdb\u4e2d\u7684\u7814\u53d1\u9879\u76ee\u4e3a\u516c\u53f8\u7684\u957f\u671f\u4ef7\u503c\u63d0\u4f9b\u4e86\u80cc\u4e66\u3002<\/p>\n<p>\u5728\u57fa\u56e0\u7f16\u8f91\u9886\u57df\uff0cCRISPR Therapeutics\uff08CRSP\uff09\u4e0eVertex Pharmaceuticals\u5408\u4f5c\u7814\u53d1\u7684\u57fa\u56e0\u7597\u6cd5Casgevy\u83b7\u5f97FDA\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u75c5\u4e0e\u03b2\u5730\u4e2d\u6d77\u8d2b\u8840\u3002\u8fd9\u662f\u9996\u4e2a\u5229\u7528CRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u83b7\u6279\u4e0a\u5e02\u7684\u7597\u6cd5\uff0c\u5f15\u53d1\u4e86\u884c\u4e1a\u8f70\u52a8\u3002\u5c3d\u7ba1CRISPR\u5f53\u524d\u5c1a\u672a\u76c8\u5229\uff0c\u4f46\u5728\u5e7f\u9614\u7684\u764c\u75c7\u3001\u514d\u75ab\u548c\u5fc3\u8840\u7ba1\u6cbb\u7597\u8d5b\u9053\u4e0a\u5df2\u5177\u5907\u5148\u53d1\u4f18\u52bf\u3002<\/p>\n<p>\u57fa\u56e0\u7ec4\u6295\u8d44\u5bf9\u4e8e\u8bb8\u591a\u6295\u8d44\u4eba\u6765\u8bf4\u5e76\u4e0d\u7b80\u5355\u3002\u8bb8\u591a\u516c\u53f8\u7531\u9876\u5c16\u79d1\u5b66\u5bb6\u6216\u8bfa\u5956\u5f97\u4e3b\u521b\u529e\uff0c\u4f46\u5e38\u5e38\u56e0\u4e3a\u7814\u53d1\u8fdb\u5c55\u7684\u4e0d\u786e\u5b9a\u6027\uff0c\u80a1\u4ef7\u6ce2\u52a8\u5267\u70c8\u3002\u7136\u800c\uff0c\u5982\u679c\u5c06\u57fa\u56e0\u7ec4\u4f01\u4e1a\u7684\u5546\u4e1a\u6a21\u5f0f\u6bd4\u4f5c\u79d1\u6280\u516c\u53f8\uff0c\u6216\u8bb8\u5c31\u80fd\u66f4\u597d\u5730\u7406\u89e3\uff1a\u6d4b\u5e8f\u516c\u53f8\u72b9\u5982\u6570\u636e\u5904\u7406\u5de8\u5934\uff0c\u68c0\u6d4b\u516c\u53f8\u7c7b\u4f3c\u4e8e\u63d0\u4f9b\u5173\u952e\u4fe1\u606f\u7684\u7535\u5546\u5e73\u53f0\uff0c\u800c\u5c1a\u5728\u9a8c\u8bc1\u9636\u6bb5\u7684\u57fa\u56e0\u7f16\u8f91\u4f01\u4e1a\u5219\u66f4\u50cf\u5c1a\u65e0\u6536\u5165\u3001\u5374\u6709\u673a\u4f1a\u51ed\u501f\u6280\u672f\u53d8\u9769\u5728\u672a\u6765\u5927\u653e\u5f02\u5f69\u7684\u521d\u521b\u516c\u53f8\u3002<\/p>\n<p>\u5982\u4eca\uff0c\u968f\u7740\u57fa\u56e0\u7ec4\u5b66\u5728\u533b\u7597\u53ca\u79d1\u7814\u9886\u57df\u7684\u6e17\u900f\u4e0d\u65ad\u52a0\u6df1\uff0c\u5e02\u573a\u5bf9\u57fa\u56e0\u7ec4\u516c\u53f8\u7684\u9700\u6c42\u52bf\u5fc5\u6301\u7eed\u6500\u5347\u3002\u65e0\u8bba\u662f\u9009\u62e9\u4e13\u6ce8\u67d0\u4e00\u4e2a\u7ec6\u5206\u95e8\u7c7b\uff0c\u8fd8\u662f\u91c7\u7528\u591a\u5143\u5316\u5efa\u4ed3\u7684\u201c\u7ec4\u5408\u7b56\u7565\u201d\uff0c\u5bf9\u4e8e\u6709\u8010\u5fc3\u4e14\u6ce8\u91cd\u957f\u671f\u4ef7\u503c\u7684\u6295\u8d44\u8005\u800c\u8a00\uff0c\u57fa\u56e0\u7ec4\u80a1\u7968\u6216\u8bb8\u6b63\u662f\u503c\u5f97\u62bc\u6ce8\u7684\u4e0b\u4e00\u7247\u84dd\u6d77\u3002\u5982\u679c\u80fd\u591f\u7a7f\u8d8a\u77ed\u671f\u6ce2\u52a8\uff0c\u642d\u4e0a\u533b\u7597\u4e0e\u79d1\u6280\u878d\u5408\u7684\u4e1c\u98ce\uff0c\u201c\u57fa\u56e0\u7ec4\u9769\u547d\u201d\u6216\u5c06\u4e3a\u6295\u8d44\u7ec4\u5408\u5e26\u6765\u5168\u65b0\u7684\u589e\u957f\u673a\u9047\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fc7\u53bb\u51e0\u5e74\uff0c\u57fa\u56e0\u7ec4\u9886\u57df\u7684\u53d1\u5c55\u8ba9\u6295\u8d44\u8005\u770b\u5230\u4e86\u771f\u6b63\u7684\u672a\u6765\u6f5c\u529b\u3002\u57fa\u56e0\u7ec4\u5b66\u6240\u7814\u7a76\u7684\u662f\u57fa\u56e0\u5982\u4f55\u5f71\u54cd\u4eba\u7c7b\u5065\u5eb7\u53ca\u75be\u75c5\uff0c\u968f\u7740\u6d4b\u5e8f [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":565254,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[513,455,747,925],"class_list":["post-565253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-513","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/565253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=565253"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/565253\/revisions"}],"predecessor-version":[{"id":565261,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/565253\/revisions\/565261"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/565254"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=565253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=565253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=565253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}